Results 11 to 20 of about 13,918 (210)

SABR for oligometastatic renal cell carcinoma

open access: yesClinical and Translational Radiation Oncology
Stereotactic ablative body radiotherapy (SABR) aims to accurately deliver a higher than conventional dose of radiotherapy to a well-defined target tumour incorporating advanced immobilisation and imaging techniques.
Chang David   +8 more
doaj   +3 more sources

The psychology of Sabr: toward a conceptual framework of resilience and coping for Palestinian muslims facing collective trauma [PDF]

open access: yesnpj Mental Health Research
The concept of Sabr (patient endurance) is central to Islamic spirituality yet remains significantly under-theorized in mental health research. In this Perspective, I argue that Sabr offers a culturally grounded framework for understanding resilience ...
Ibrahim Aqtam
doaj   +3 more sources

A spectacular tumor response of a giant axillary mass treated with SABR in a palliative scenario

open access: yesBrazilian Journal of Oncology, 2021
A 67-year-old male patient with a massive left axillary metastasis from an occult primary tumor (OPT) treated by stereotactic ablative radiotherapy (SABR) is presented. The patient had no clinical response to the initial chemotherapy treatment.
Fernando Kojo Matsuura   +5 more
doaj   +2 more sources

Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial

open access: yesJournal for ImmunoTherapy of Cancer
Background The recent phase II randomized stereotactic ablative radiotherapy with and without immunotherapy (I-SABR) trial has shown improved event-free survival (EFS) when adding immunotherapy to stereotactic ablative radiotherapy (SABR) for early-stage
Vivek Verma   +21 more
doaj   +2 more sources

Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care

open access: yesTechnical Innovations & Patient Support in Radiation Oncology
Highlights • We describe the evolution of pelvic SABR reirradiation in the UK.• National guidance for pelvic SABR reirradiation published in full in Appendix.• Full description and examples of calculation method for cumulative dose constraints ...
E. Moreno-Olmedo   +20 more
semanticscholar   +2 more sources

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease [PDF]

open access: yesOncoImmunology
Stereotactic ablative radiotherapy (SABR) may extend the clinical benefit of immune checkpoint inhibitors (ICI) in patients with oligoprogressive disease. However, individual benefit varies, and validated biomarkers to guide patient selection are lacking.
Juan Zafra-Martin   +14 more
doaj   +2 more sources

Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre [PDF]

open access: yesCancers, 2023
Simple Summary Surgery or conventional radical radiotherapy are established curative treatment options for patients with localised, stage I non-small-cell lung cancer (NSCLC).
M. Stares   +14 more
semanticscholar   +2 more sources

From Clinical Trials to Clinical Practice–Patterns of Practice Survey on Prostate SABR in Australia and New Zealand [PDF]

open access: yesAdvances in Radiation Oncology
Purpose: Prostate stereotactic ablative body radiotherapy (SABR) is now a standard-of-care radiation therapy option for prostate cancer based on high-level clinical trial evidence.
Therese Kang, MBBS   +16 more
doaj   +2 more sources

Oncologic outcomes and renal function preservation after stereotactic ablative body radiotherapy versus radiofrequency ablation in stage I renal cell carcinoma [PDF]

open access: yesClinical and Translational Radiation Oncology
Purpose: This study compared stereotactic ablative body radiotherapy (SABR) and radiofrequency ablation (RFA) in patients with biopsy-proven stage I renal cell carcinoma (RCC), focusing on oncologic outcomes and renal function outcomes. Methods: Patients
Ye Jin Yoo   +5 more
doaj   +2 more sources

SabR enhances nikkomycin production via regulating the transcriptional level of sanG, a pathway-specific regulatory gene in Streptomyces ansochromogenes [PDF]

open access: yesBMC Microbiology, 2011
Background sabR is a pleiotropic regulatory gene which has been shown to positively regulate the nikkomycin biosynthesis and negatively affect the sporulation of Streptomyces ansochromogenes.
Liu Gang   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy